| Mrs Renda K Knapp, MD | |
|
4136 Bartlett Street, Homer, AK 99603-7001 | |
| (907) 235-8586 | |
| (907) 235-6639 |
| Full Name | Mrs Renda K Knapp |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 4136 Bartlett Street, Homer, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922015098 | NPI | - | NPPES |
| 1523700 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 103505 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Peninsula Hospital | Homer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Peninsula Hospital Inc | 5395636930 | 43 |
News Archive
A new study published in the Journal of Consumer Affairs finds that women from rural populations are motivated to seek breast cancer prevention screenings primarily out of concern for the long-term well being of their families. The study shows that by appealing to their strength as caretakers doctors can encourage their rural patients to perform breast health self-examinations, get mammograms, and to talk with doctors about their breast health.
Pancreatic cancer has a devastatingly low survival rate (less than 5 percent after 5 years) because it is usually diagnosed at an advanced stage. The initial symptoms, such as pain, jaundice, or weight loss, often do not allow the disease to be caught early enough for surgery and chemotherapy to be effective.
Virginia Gov. Bob McDonnell, however, says he is considering opting out but would like more answers - both in terms of policy questions and the political outcome of the election - before he makes a decision. Meanwhile, Stateline explores how the Medicaid expansion will present a tough fiscal call for many of state executives.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
› Verified 8 days ago
| Entity Name | South Peninsula Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
A new study published in the Journal of Consumer Affairs finds that women from rural populations are motivated to seek breast cancer prevention screenings primarily out of concern for the long-term well being of their families. The study shows that by appealing to their strength as caretakers doctors can encourage their rural patients to perform breast health self-examinations, get mammograms, and to talk with doctors about their breast health.
Pancreatic cancer has a devastatingly low survival rate (less than 5 percent after 5 years) because it is usually diagnosed at an advanced stage. The initial symptoms, such as pain, jaundice, or weight loss, often do not allow the disease to be caught early enough for surgery and chemotherapy to be effective.
Virginia Gov. Bob McDonnell, however, says he is considering opting out but would like more answers - both in terms of policy questions and the political outcome of the election - before he makes a decision. Meanwhile, Stateline explores how the Medicaid expansion will present a tough fiscal call for many of state executives.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Renda K Knapp, MD 4136 Bartlett Street, Homer, AK 99603-7001 Ph: (907) 235-8586 | Mrs Renda K Knapp, MD 4136 Bartlett Street, Homer, AK 99603-7001 Ph: (907) 235-8586 |
News Archive
A new study published in the Journal of Consumer Affairs finds that women from rural populations are motivated to seek breast cancer prevention screenings primarily out of concern for the long-term well being of their families. The study shows that by appealing to their strength as caretakers doctors can encourage their rural patients to perform breast health self-examinations, get mammograms, and to talk with doctors about their breast health.
Pancreatic cancer has a devastatingly low survival rate (less than 5 percent after 5 years) because it is usually diagnosed at an advanced stage. The initial symptoms, such as pain, jaundice, or weight loss, often do not allow the disease to be caught early enough for surgery and chemotherapy to be effective.
Virginia Gov. Bob McDonnell, however, says he is considering opting out but would like more answers - both in terms of policy questions and the political outcome of the election - before he makes a decision. Meanwhile, Stateline explores how the Medicaid expansion will present a tough fiscal call for many of state executives.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.
› Verified 8 days ago
Kathryn H Ostrom, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 205 W Fairview Ave, Homer, AK 99603 Phone: 907-435-0555 Fax: 833-992-2172 |